Rapid and sensitive detection of cell-associated HIV-1 in latently infected cell lines and in patient cells using sodium-n-butyrate induction and RT-PCR

作者: Fatah Kashanchi , Jacqueline C. Melpolder , Jay S. Epstein , M. Reza Sadaie

DOI: 10.1002/(SICI)1096-9071(199706)52:2<179::AID-JMV11>3.0.CO;2-G

关键词:

摘要: To develop a rapid and sensitive means of detecting cell-associated human immunodeficiency virus (HIV), donor cells from HIV seropositive patients were treated with the potent viral activator sodium-n-butyrate (NaB) subsequently assayed by both in situ RNA hybridization reverse transcriptase polymerase chain reaction (RT-PCR). The sensitivity RT-PCR was estimated to be equivalent 1 x 10(-16) grams (0.1 fg) or approximately 64 copies input standard per reaction. present study takes advantage ability NaB introduce changes chromatin structure latently infected cells, leading increased gene expression. Human ACH-2 U1 cell lines used as representatives T-lymphocytic monocytoid harboring latent inducible proviruses. expression readily detected when these NaB. Viral gag assays. When peripheral blood mononuclear (PBMCs) acquired syndrome (AIDS) patients, who all negative for serum/plasma p24 assays, detection expression, four categories distinct patterns induction observed. first set showed HIV-positive PBMCs without any added NaB, suppression PHA. second samples alone. third could induced PHA, but not fourth required PHA Our results suggest that direct treatment activators may useful increasing intended RNAs. This approach confirm true status infection are RNAs below threshold detection. Moreover, this method identify presence proviral genomes possibly reflecting rate load vivo possible mutations brought about long-term co-cultivation assays seronegative donors.

参考文章(41)
M.J.W. Visseren, R.M.P. Brandt, S.H. van der Burg, W.M. Kast, C.J.M. Melief, Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. Journal of Immunology. ,vol. 156, pp. 3308- 3314 ,(1996)
WA O'Brien, K Grovit-Ferbas, A Namazi, S Ovcak-Derzic, HJ Wang, J Park, C Yeramian, SH Mao, JA Zack, Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination Blood. ,vol. 86, pp. 1082- 1089 ,(1995) , 10.1182/BLOOD.V86.3.1082.1082
K Saksela, E Muchmore, M Girard, P Fultz, D Baltimore, High viral load in lymph nodes and latent human immunodeficiency virus (HIV) in peripheral blood cells of HIV-1-infected chimpanzees. Journal of Virology. ,vol. 67, pp. 7423- 7427 ,(1993) , 10.1128/JVI.67.12.7423-7427.1993
David N. Posnett, Shara Kabak, Dana Dobrescu, Andrew S. Hodtsev, The HIV-1 reservoir in distinct Vβ subsets of CD4 T cells : evidence for a putative superantigen Journal of Clinical Immunology. ,vol. 15, ,(1995) , 10.1007/BF01540889
S. A. Fiscus, V. DeGruttola, P. Gupta, D. A. Katzenstein, W. A. Meyer, M. L. LoFaro, M. Katzman, M. V. Ragni, P. S. Reichelderfer, R. W. Coombs, Human Immunodeficiency Virus Type 1 Quantitative Cell Microculture as a Measure of Antiviral Efficacy in a Multicenter Clinical Trial The Journal of Infectious Diseases. ,vol. 171, pp. 305- 311 ,(1995) , 10.1093/INFDIS/171.2.305
Guowei Fang Guowei Fang, H Burger, R Grimson, P Tropper, S Nachman, D Mayers, O Weislow, R Moore, C Reyelt, N Hutcheon, D Baker, B Weiser, Maternal plasma human immunodeficiency virus type 1 RNA level: A determinant and projected threshold for mother-to-child transmission Proceedings of the National Academy of Sciences of the United States of America. ,vol. 92, pp. 12100- 12104 ,(1995) , 10.1073/PNAS.92.26.12100
M. G. RIGGS, R. G. WHITTAKER, J. R. NEUMANN, V. M. INGRAM, n -Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells Nature. ,vol. 268, pp. 462- 464 ,(1977) , 10.1038/268462A0
Francois Ferre, Ana L. Marchese, Stacey L. Griffin, Anne E. Daigle, Steven P. Richieri, Fred C. Jensen, Dennis J. Carlo, Development and validation of a polymerase chain reaction method for the precise quantitation of HIV-1 DNA in blood cells from subjects undergoing a 1-year immunotherapeutic treatment. AIDS. ,vol. 7, ,(1993) , 10.1097/00002030-199311002-00006